Skip to content

Electroacupuncture for pain improvement in patients with postherpetic neuralgia : a single arm pilot study

Electroacupuncture for pain improvement in patients with postherpetic neuralgia : a single arm pilot study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005386
Enrollment
Unknown
Registered
2021-12-09
Start date
2021-12-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Sponsors

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Over 50 years old; ? Meet the diagnostic criteria of postherpetic neuralgia in the consensus of Chinese experts on the diagnosis and treatment of postherpetic neuralgia in 2016; ? Agree to receive acute analgesics; ? The average highest pain vas = 3 points within 1 week of the screening period; ? The patient signed the informed consent form and voluntarily participated in the trial.

Exclusion criteria

Exclusion criteria: ? Previous neurolytic block or neurosurgical treatment; ? Pain unrelated to PHN; ? Have emotional disorders and need to take tricyclic antidepressants, mental and intellectual disorders; ? Complicated with serious primary diseases such as cardio cerebrovascular, liver, kidney and hematopoietic system, as well as other organic diseases such as tumors; ? Pregnant and lactating women or women who have fertility requirements in recent half a year; ? Poor blood glucose control, glycosylated hemoglobin = 8%; ? Anemia, untreated hypothyroidism or history of HIV infection and other immunodeficiency diseases and hepatitis B antigen or hepatitis C antibody positive history, active tuberculosis and other patients; ? Patients who had previously received acupuncture treatment; ? Belongs to the vulva and brachial plexus region and special types of herpes zoster, including PHN caused by eye, ear herpes zoster, contusion herpes zoster, herpes zoster free, herpes zoster meningitis or encephalitis, herpes zoster invading visceral nerve fibers, disseminated herpes zoster and others (herpes zoster with bullous, hemorrhagic, gangrenous and other manifestations); ? Participate in other clinical trials at the same time.

Design outcomes

Primary

MeasureTime frame
VAS responder rate(=50%);

Countries

China

Contacts

Public ContactBin Li
libin@bjzhongyi.com18910781852

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026